Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Perretta-Tejedor

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cellular Signalling|April 4, 2020
Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signallingNuria Perretta-Tejedor, Daniyal J Jafree, David A Long
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2019
Generating Mutant Renal Cell Lines Using CRISPR TechnologiesNuria Perretta-Tejedor, Grace Freke, Marian Seda, et al.
Biochimica Et Biophysica Acta|March 6, 2014
ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblastsJosé M Muñoz-Félix, Nuria Perretta-Tejedor, Nélida Eleno, et al.
Physiological Reports|July 2, 2024
Cardiotrophin-1 therapy reduces disease severity in a murine model of glomerular diseaseNuria Perretta-Tejedor, Karen L Price, Daniyal J Jafree, et al.
Cellular Signalling|May 22, 2016
Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitroJosé M Muñoz-Félix, Cristina Cuesta, Nuria Perretta-Tejedor, et al.
Scientific Reports|June 12, 2020
Association of Alk1 and Endoglin Polymorphisms with Cardiovascular DamageMercedes Garzon-Martinez, Nuria Perretta-Tejedor, Luis Garcia-Ortiz, et al.
BMJ Open|April 5, 2014
Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension)Manuel A Gomez-Marcos, Rogelio Gonzalez-Sarmiento, José I Recio-Rodríguez, et al.
Acta Physiologica (Oxford, England)|December 28, 2018
Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney diseaseNuria Perretta-Tejedor, José M Muñoz-Félix, Annette Düwel, et al.
Physiological Reports|January 17, 2025
Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney diseaseLauren G Russell, Maria Kolatsi-Joannou, Laura Wilson, et al.
Scientific Reports|May 12, 2018
Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factorsNuria Perretta-Tejedor, Javier Fernández-Mateos, Luis García-Ortiz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cellular Signalling|April 4, 2020
Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signallingNuria Perretta-Tejedor, Daniyal J Jafree, David A Long
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2019
Generating Mutant Renal Cell Lines Using CRISPR TechnologiesNuria Perretta-Tejedor, Grace Freke, Marian Seda, et al.
Biochimica Et Biophysica Acta|March 6, 2014
ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblastsJosé M Muñoz-Félix, Nuria Perretta-Tejedor, Nélida Eleno, et al.
Physiological Reports|July 2, 2024
Cardiotrophin-1 therapy reduces disease severity in a murine model of glomerular diseaseNuria Perretta-Tejedor, Karen L Price, Daniyal J Jafree, et al.
Cellular Signalling|May 22, 2016
Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitroJosé M Muñoz-Félix, Cristina Cuesta, Nuria Perretta-Tejedor, et al.
Scientific Reports|June 12, 2020
Association of Alk1 and Endoglin Polymorphisms with Cardiovascular DamageMercedes Garzon-Martinez, Nuria Perretta-Tejedor, Luis Garcia-Ortiz, et al.
BMJ Open|April 5, 2014
Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension)Manuel A Gomez-Marcos, Rogelio Gonzalez-Sarmiento, José I Recio-Rodríguez, et al.
Acta Physiologica (Oxford, England)|December 28, 2018
Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney diseaseNuria Perretta-Tejedor, José M Muñoz-Félix, Annette Düwel, et al.
Physiological Reports|January 17, 2025
Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney diseaseLauren G Russell, Maria Kolatsi-Joannou, Laura Wilson, et al.
Scientific Reports|May 12, 2018
Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factorsNuria Perretta-Tejedor, Javier Fernández-Mateos, Luis García-Ortiz, et al.
Pageof 2